Marketing Strategies for Medical Spas in Q4

Marketing Strategies for Medical Spas in Q4

What to do if business is slow. The end of Q3-2023 brought about notable industry shifts for medical spas across the country, with a decline in customer acquisition and growth challenges impacting many practices. Regardless of the size of your practice, it’s...
Daxxify Slashes Price to Take Market Share From Botox

Daxxify Slashes Price to Take Market Share From Botox

Daxxify is a new FDA-approved neuromodulator by Revance Therapeutics (“Revance”) designed to soften the look of fine lines and wrinkles. Daxxify differs from Botox and other botulinum toxin injectables, like Xeomin, Juveau, and Dysport, in that it is designed to work...